ICAM1 and diabetes mellitus: Furthermore, shared epigenetic mechanisms, including methylation changes in inflammatory gene promoters (e.g., IL6, TNF, and ICAM1), histone acetylation/deacetylation, and altered microRNA expression, have been reported in patients with PD, DM, and CVD.